Ownership history in ProShare Advisors LLC Β· 18 quarters on record
This page tracks every 13F SEC filing in which ProShare Advisors LLC reported a position in CROSS CTRY HEALTHCARE INC COM (CCRN). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price β sourced directly from SEC EDGAR 13F filings.
π ProShare Advisors LLC underperformed the S&P 500 by β47.4% annually on this CCRN position. Timing score: 29% (5/17 decisions correct). Average cost basis: $12.44. Maximum drawdown during holding period: β68.3%.
β Significantly underperformed the S&P 500 by 47.4% ann.
17 quarters analyzed
β οΈ Poor timing β buys often preceded drops, trims preceded rallies.
5 of 17 add/trim decisions correct
Best entry: $5.16 (2013 Q2) Β· Worst: $18.16 (2024 Q4)
πͺ Held through 2 major drawdowns (>20%).
7 adds Β· 11 trims. Bought during 5 of 8 down-price quarters. π Predominantly trimming β distribution phase.
βοΈ Portfolio weight has remained relatively stable β conviction maintained.
Currently 0.0% of portfolio
β Based on quarterly 13F SEC filings and end-of-quarter closing prices. Timing score = accuracy of add/trim decisions vs next-quarter price direction. Alpha = mean quarterly excess return Γ 4 (annualised). Not investment advice.
As of 2025 Q4 β sorted by position size